Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis

AIMS: The effects of FGF21 on Parkinson's disease (PD) and its relationship with gut microbiota have not been elucidated. This study aimed to investigate whether FGF21 would attenuate behavioral impairment through microbiota–gut–brain metabolic axis in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Changwei, Wang, Wuqiong, Deng, Pengxi, Wang, Xinyi, Zhu, Lin, Zhao, Liangcai, Li, Chen, Gao, Hongchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651963/
https://www.ncbi.nlm.nih.gov/pubmed/37334756
http://dx.doi.org/10.1111/cns.14302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651963/
https://www.ncbi.nlm.nih.gov/pubmed/37334756
http://dx.doi.org/10.1111/cns.14302

Ejemplares similares